A team of scientists in Norway has found evidence for a new mechanism for the development of cancer in children: They seem to ...

The 3rd European Congress on Infectious Diseases & Immunology, taking place on August 11–12, 2027, in London, UK, is a ...

Does that mean Californians ought to approve $8.4 billion in bonds to approve a plan developed outside the legislative ...

Johnson & Johnson is downgraded to a Hold, citing mixed fundamentals and regulatory headwinds. Read more on JNJ stock here.

“If HIV treatments are stopped for even a short period of time, the virus can come surging back. But scientists are working ...

Researchers at MD Anderson developed an AI tool called SPACER that decodes the spatial signals attracting or repelling immune ...

A preclinical study by researchers at UT Southwestern Medical Center has discovered how a protein called ZBTB44 helps prevent excessive immune activity that can cause inflammation in the colon, the ...

"Tremfya rescues J&J's immunology sales to fuel strong Q3" was originally created and published by Medical Device Network, a ...

New members bring expertise in emerging viruses, surveillance, respiratory and arboviral diseases, One Health, antiviral development and pandemic preparedness ...

Nimbus Therapeutics, a Boston-based computational drug discovery company, has announced three senior leadership appointments as it advances its pipeline of... Read More ...

Since the drug’s approval and launch earlier this year, J&J has recorded more than 20,000 patient starts on Icotyde, funneled ...